(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Help Your Efficiency with These Work area Updates - 2Figure out How to Get the Best Open Record Rewards
- 3Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- 4They died 'doing what they loved': The stories of workers in their 80s who died on the job
- 5Find Your Ideal Tea: Six Particular Assortments
- Manual for Tracking down the Nearby Business sectors and Marketplaces
- Photos: Presidential turkey pardons — a look back
- A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue
- Man who grabbed Ariana Grande at 'Wicked: For Good' premiere also rushed Katy Perry onstage this year. Who is he and why is he doing this?
- Lego's $650 Pokémon set is already sold out as demand, preorders surge
- Meet Beef the bulldog, who takes slow walks with his 78-year-old friend
- Zelensky confidant dismissed from further posts amid bribery scandal
- Figure out how to Guarantee Your Dental Embeds Endure forever
- A Manual for SUVs with Less Noteworthy Gas Mileage
